The rate of appendix cancer has tripled among Generation X and quadrupled among millennials compared to previous generations, a new study found. The study, published June 10 in Annals of Internal ...

The disease runs in my family, but I'm living proof that survival rates are improving for cancer patients, thanks to medical ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

The Varian Ethos 2.0 technology is part of UH's broader cancer care initiative, which includes a new $39 million regional ...

A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, ...

Future studies will investigate long-term implications of FMT on host metabolism and immune function, and effects on brain ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

Learn the crucial differences between IBS and colon cancer symptoms, risk factors, and treatments to protect your digestive ...

In the realm of colorectal cancer treatments beyond surgery and radiation, one key question gained prominence in recent years ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of ...